We are currently experimenting with pharma ceutical drug library consisting of

Go down

 We are currently experimenting with pharma ceutical drug library consisting of  Empty We are currently experimenting with pharma ceutical drug library consisting of

Post  wangqian on Thu Apr 03, 2014 6:56 am

The first step in inference is prediction of sensitivity val ues for target combinations outside the known dataset. Consider that the set of drug representations, con sists of c unique elements. In addition, the number of targets added to the minimizing target set is n. The total possible target combinations is then 2n for bina AP24534 ic50 rized target inhibition, and there are thus unknown target combination sensitivities. We would like to be able to perform inference on any of the unknown sen sitivity combination, and we would like to utilize known sensitivities whenever possible. To begin the inference step, let us first recall the 2 com plementary rules for kinase target behavior upon which we base this model. Rule 3 follows from the first two rules; rule 1 provides that any superset will have greater sensitivity, and rule 2 knowledge or pre modeling analysis.

Given this vector , we will define yi as follows: provides that any subset will have lower sensitivity. To apply rule 3 in practical situations, we must guaran AT7519 分子量 tee that every combination will have a subset and superset with an experimental value. We will assume that the target combination that inhibits all targets in T will be very effective, and as such will have sensitivity 1. In addition, the target combination that consists of no inhi bition of any target, which is essentially equivalent to no treatment of the disease, will have no effectiveness, and as such will have a sensitivity of 0. Either of these can be substituted with experimental sensitivity values that have the corresponding target combination.

In numerous prac tical scenarios, the target combination of no inhibition has sensitivity 0. With the lower and upper bound of the target combi nation purchase Alisertib sensitivity fixed, we now must perform the infer ence step by predicting, based on the distance between the subset and superset target combinations. We per form this inference based on binarized inhibition, as the inference here is meant to predict the sensitivity of target combinations with non specific EC50 values. Refining sensitivity predictions further based on actual drugs with specified EC50 values will be considered later. of an additional d targets, denoted t1, t2, td, and the remaining h−d, denoted td 1, th targets will remain uncontrolled.

For naive inference, we can consider that over the course of the addition of the h targets needed to transition from to, the change in sensi tivity due to the addition of each target is uniform. With as the lower bound of the drug sensitivity, the resulting naive sensitivity from the addition of d2 h targets is With the inference function defined as above, we can create a prediction for the sensitivity of any binarized kinase target combination relative to the target set T; thus we can infer all of unknown sensitivities from the experimental sensitivities, creating a complete map of the sensitivities of all possible kinase target based therapies relevant for the patient. As noted previously, this complete set of sensitivity combinations constitutes the TIM. The TIM effectively captures the variations of target combina tion sensitivities across a large target set.


Posts : 100
Join date : 2014-02-25

View user profile

Back to top Go down

Back to top

- Similar topics

Permissions in this forum:
You cannot reply to topics in this forum